Week of May 16, 2023 | Vol. 12, Issue 19

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

UpHealth Announces Closing of Sale of Innovations Group Incorporated to Belmar Pharma Solutions for $56.0 Million in Gross Proceeds

Bourne Partners - May 11, 2023

Ginkgo Bioworks Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases

PR Newswire - May 8, 2023

Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of Inexin™

Societal CDMO - May 8, 2023

Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging-Related Diseases

Business Wire - May 8, 2023

Baxter to sell BPS business to Advent and Warburg Pincus for $4.25bn

Pharmaceutical Technology - May 9, 2023

Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies

PR Newswire - May 9, 2023

Syneos To Be Acquired By Private Investment Consortium For $7.1B, Q1 Earnings Beat Expectations

Yahoo Finance - May 10, 2023

Spain's Henko Partners looks to form European CRO with latest investments

Fierce Biotech - May 10, 2023

Wacker Purchases ADL BioPharma in €100M Deal

Contract Pharma - May 11, 2023

Genesis acquires Canadian CRO JSS Medical Research to expand global reach

Fierce Biotech - May 11, 2023

Evotec Biologics, Sandoz Enter Biosimilars Development & Mfg. Pact

Contract Pharma - May 11, 2023

TANNER NEWS

Getting Medicines to Patients in Need

While some drugs are in short supply due to supply bottlenecks and other logistical reasons, many have been discontinued or are not yet cleared for use in the same country as the patients that urgently need them. We discuss how Tanner manages disruptions in the pharma market and ensures treatments reach patients quickly and compliantly - no matter their location. Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.